Literature DB >> 6738366

Total and individual free fatty acid concentrations in liver cirrhosis.

O Riggio, M Merli, A Cantafora, A Di Biase, L Lalloni, F Leonetti, P Miazzo, V Rinaldi, F Rossi-Fanelli, G Tamburrano.   

Abstract

The finding of high plasma free fatty acid (FFA) levels in cirrhotic patients has been attributed either to decreased hepatic clearance or to enhanced fat mobilization. To better clarify these hypotheses, total and individual FFA and glycerol levels were determined in 21 cirrhotic patients with different degrees of hepatocellular damage (evaluated by liver function tests), portal hypertension (evaluated by endoscopy and clinical signs), and nutritional status (evaluated by anthropometric and biohumoral parameters) and in 10 age- and sex-matched healthy subjects. Glucose tolerance and insulin and glucagon levels were determined in all individuals. Well-nourished and malnourished patients were identified within the cirrhotic group. Plasma FFA and glycerol concentrations were well correlated (r = 0.47, P less than 0.05), levels being significantly higher in cirrhotic individuals than in controls (746.6 +/- 46.29 SE v 359.22 +/- 40.82 mumol/L, P less than 0.001 for plasma FFA; 150.1 +/- 3.12 v 82.5 +/- 9.2 mumol/L, P less than 0.01 for glycerol). Plasma FFA and glycerol showed no correlation with the liver function test results or portal hypertension parameters. Interestingly, plasma levels of FFA and glycerol were influenced by the nutritional status, significantly higher FFA levels being observed in the well-nourished than in the malnourished patients (842.5 +/- 47.5 v 563.4 +/- 78 mumol/L, P less than 0.005). Furthermore, a positive correlation was found between plasma glycerol level and percentage of triceps skinfold (r = 0.45, P less than 0.05). No correlation was found between plasma levels of FFA or glycerol and glucose tolerance, insulin and glucagon.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738366     DOI: 10.1016/0026-0495(84)90064-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

Review 1.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

2.  Resistance to insulin suppression of plasma free fatty acids in liver cirrhosis.

Authors:  M Merli; F Leonetti; O Riggio; A Giaccari; A Romiti; P Sbraccia; G Tamburrano
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

3.  Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.

Authors:  A V Greco; G Mingrone; A Mari; E Capristo; M Manco; G Gasbarrini
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

4.  Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.

Authors:  A S Petrides; L C Groop; C A Riely; R A DeFronzo
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 5.  Metabolic Optimisation of Regulatory T Cells in Transplantation.

Authors:  Mo Atif; Audrey Mohr; Filomena Conti; Olivier Scatton; Guy Gorochov; Makoto Miyara
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.